| Adverse events following remdesivir administration in moderately ill COVID-19 patients-A retrospective analysis R Gandham, M Eerike, GM Raj, D Bisoi, R Priyadarshini, N Agarwal Journal of family medicine and primary care 11 (7), 3693-3698, 2022 | 8 | 2022 |
| Anti-spike Antibody Status in Pre-vaccinated Healthy Participants and Rheumatoid Arthritis Patients During the Third Wave of COVID-19 M Eerike, R Sundaramurthy, R Gandham, V Sakthivadivel, A Amshala, ... Cureus 15 (4), 2023 | | 2023 |
| Assessing the Efficacy of the ARMOR Tool–Based Deprescribing Intervention for Fall Risk Reduction in Older Patients Taking Fall Risk–Increasing Drugs (DeFRID Trial): Protocol … R Priyadarshini, M Eerike, S Varatharajan, G Ramaswamy, GM Raj, ... JMIR research protocols 13 (1), e55638, 2024 | | 2024 |
| Association of plasma docetaxel levels with ABCB1 gene polymorphisms and tumour response in locally advanced breast cancer patients of South India on neo … R Priyadarshini, GM Raj, R Sundaram, S Kayal, A Ramesh, DG Shewade Breast Cancer 28, 414-423, 2021 | 3 | 2021 |
| Chromatography - the essence of bioanalysis R Priyadarshini, M Raj, G Shewade European Journal of Biomedical and Pharmaceutical Sciences 3 (1), 366-377, 2016 | 13 | 2016 |
| Clinical and immunological responses to COVID-19 vaccination in rheumatoid arthritis patients on disease modifying antirheumatic drugs: a cross-sectional study M Eerike, VP Parimi, A Pyati, R Sundaramurthy, V Sakthivadivel, ... Journal of Rheumatic Diseases 31 (1), 15, 2024 | 1 | 2024 |
| Current Perspectives in the Management of Hypertension GM Raj, R Priyadarshini, J Mathaiyan Scholarena 1 (1), 1, 0 | | |
| Drug patents and intellectual property rights GM Raj, R Priyadarshini, J Mathaiyan European Journal of Clinical Pharmacology 71, 403-409, 2015 | 16 | 2015 |
| Drug transporters R Priyadarshini Introduction to Basics of Pharmacology and Toxicology: Volume 1: General and …, 2019 | 3 | 2019 |
| Effect of ABCB1 gene polymorphisms C3435T and C1236T on tumour response and plasma levels of docetaxel in locally-advanced breast cancer patients of South India receiving neo … R Priyadarshini, S Kayal, DG Shewade Annals of Oncology 27, vi90, 2016 | 1 | 2016 |
| Efficacy and Safety of Anti-SARS-CoV-2 Monoclonal Antibodies: An Updated Review G Ravi, M Eerike, VR Konda, D Bisoi, GM Raj, R Priyadarshini, KR Mali, ... Monoclonal Antibodies in Immunodiagnosis and Immunotherapy 42 (2), 77-94, 2023 | 4 | 2023 |
| Efficacy and safety of Molnupiravir in COVID-19 patients: A systematic review KR Mali, M Eerike, GM Raj, D Bisoi, R Priyadarshini, G Ravi, ... Irish Journal of Medical Science (1971-) 192 (4), 1665-1678, 2023 | 28 | 2023 |
| Efficacy and safety of Molnupiravir in COVID‑19 patients: a systematic KR Mali, M Eerike, GM Raj, D Bisoi, R Priyadarshini, G Ravi, ... | | |
| Ethical issues in animal research GM Raj, R Priyadarshini Introduction to Basics of Pharmacology and Toxicology: Volume 3 …, 2022 | 1 | 2022 |
| General Principles of Cancer Chemotherapy R Priyadarshini Introduction to Basics of Pharmacology and Toxicology Volume 2 : Essentials …, 2021 | 1 | 2021 |
| Genetic polymorphisms of multidrug and toxin extrusion proteins (MATE1 and MATE2) in South Indian population GM Raj, J Mathaiyan, M Wyawahare, KS Rao, R Priyadarshini BioImpacts: BI 7 (1), 25, 2017 | 5 | 2017 |
| Histamine, Serotonin, Bradykinin, and the Ergot Alkaloids R Priyadarshini, GM Raj Introduction to Basics of Pharmacology and Toxicology Volume 2 : Essentials …, 2021 | 1 | 2021 |
| Hydroxychloroquine for SARS CoV2 Prophylaxis in Healthcare Workers-A Multicentric Cohort Study Assessing Effectiveness and Safety. B Dinesh, J CS, CP Kaur, F Atiya, G Yk, H Avijit, K Sandhya, K Vp, ... The Journal of the Association of Physicians of India 69 (6), 11-12, 2021 | 12 | 2021 |
| Influence of ABCB1 C3435T and C1236T gene polymorphisms on tumour response to docetaxel‐based neo‐adjuvant chemotherapy in locally advanced breast … R Priyadarshini, GM Raj, S Kayal, A Ramesh, DG Shewade Journal of Clinical Pharmacy and Therapeutics 44 (2), 188-196, 2019 | 18 | 2019 |
| Ivermectin in COVID-19 Management: What is the current evidence? M Eerike, GM Raj, R Priyadarshini, G Ravi, D Bisoi, VGR Konda Infectious Disorders-Drug Targets (Formerly Current Drug Targets-Infectious …, 2022 | 4 | 2022 |
Gerard Marshall RajAll India Institute of Medical Sciences (AIIMS) Bibinagar, Hyderabad在 aiimsbibinagar.edu.in 的电子邮件经过验证
